TY - JOUR T1 - Extended SIR prediction of the epidemics trend of COVID-19 in Italy and compared with Hunan, China JF - medRxiv DO - 10.1101/2020.03.18.20038570 SP - 2020.03.18.20038570 AU - Jia Wangping AU - Han Ke AU - Song Yang AU - Cao Wenzhe AU - Wang Shengshu AU - Yang Shanshan AU - Wang Jianwei AU - Kou Fuyin AU - Tai Penggang AU - Li Jing AU - Liu Miao AU - He Yao Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/03/20/2020.03.18.20038570.abstract N2 - Background Coronavirus Disease 2019 (COVID-19) is currently a global public health threat. Outside of China, Italy is one of the most suffering countries with the COVID-19 epidemic. It is important to predict the epidemics trend of COVID-19 epidemic in Italy to help develop public health strategies.Methods We used time-series data of COVID-19 from Jan 22,2020 to Mar 16,2020. An infectious disease dynamic extended susceptible-infected-removed (eSIR) model, which covers the effects of different intervention measures in dissimilar periods, was applied to estimate the epidemic trend in Italy. The basic reproductive number was estimated using Markov Chain Monte Carlo methods and presented using the resulting posterior mean and 95% credible interval (CI). Hunan, with similar total number of populations in Italy, was used as a comparative item.Results In the eSIR model, we estimated that the basic reproductive number for COVID-19 was respectively 4.10 (95% CI: 2.15–6.77) in Italy and 3.15(95% CI: 1.71–5.21) in Hunan. There would be totally 30 086 infected cases (95%CI:7920-81 869) under the current country blockade and the endpoint would be Apr 25 (95%CI: Mar 30 to Aug 07) in Italy. If the country blockade is imposed 5 day later, the total number of infected cases would expand the infection scale 1.50 times.Conclusion Italy’s current strict measures can efficaciously prevent the further spread of COVID-19 and should be maintained. Necessary strict public health measures be implemented as soon as possible in other European countries with a high number of COVID-19 cases. The most effective strategy needs to be confirmed in further studies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study was funded by Army Logistics Emergency Scientific Research Project; Emergency scientific research of the army and the emergency scientific research of Chinese PLA General Hospital (20EP008).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe used the publicly available dataset of COVID-19 provided by the Johns Hopkins University https://github.com/CSSEGISandData/COVID-19 ER -